CA1323748C - Rhenium generator system and method for its preparation and use - Google Patents
Rhenium generator system and method for its preparation and useInfo
- Publication number
- CA1323748C CA1323748C CA 551444 CA551444A CA1323748C CA 1323748 C CA1323748 C CA 1323748C CA 551444 CA551444 CA 551444 CA 551444 A CA551444 A CA 551444A CA 1323748 C CA1323748 C CA 1323748C
- Authority
- CA
- Canada
- Prior art keywords
- tungstate
- matrix
- precipitate
- zirconyl
- tungsten
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 229910052702 rhenium Inorganic materials 0.000 title abstract description 5
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 title abstract description 5
- 239000011159 matrix material Substances 0.000 claims abstract description 50
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 claims abstract description 34
- -1 tungstate compound Chemical class 0.000 claims abstract description 15
- WUAPFZMCVAUBPE-NJFSPNSNSA-N 188Re Chemical compound [188Re] WUAPFZMCVAUBPE-NJFSPNSNSA-N 0.000 claims abstract description 11
- WFKWXMTUELFFGS-RNFDNDRNSA-N tungsten-188 Chemical compound [188W] WFKWXMTUELFFGS-RNFDNDRNSA-N 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims description 46
- 239000002244 precipitate Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 18
- 239000010453 quartz Substances 0.000 claims description 12
- 239000003929 acidic solution Substances 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000003495 polar organic solvent Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005909 Kieselgur Substances 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims 4
- 238000009792 diffusion process Methods 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 238000010828 elution Methods 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 17
- WFKWXMTUELFFGS-NJFSPNSNSA-N tungsten-186 Chemical compound [186W] WFKWXMTUELFFGS-NJFSPNSNSA-N 0.000 abstract description 3
- 230000001678 irradiating effect Effects 0.000 abstract 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 39
- 229910052721 tungsten Inorganic materials 0.000 description 38
- 239000010937 tungsten Substances 0.000 description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- ZNOKGRXACCSDPY-UHFFFAOYSA-N tungsten trioxide Chemical compound O=[W](=O)=O ZNOKGRXACCSDPY-UHFFFAOYSA-N 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 229910052751 metal Inorganic materials 0.000 description 11
- 239000002184 metal Substances 0.000 description 11
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 10
- 239000002510 pyrogen Substances 0.000 description 9
- 229910052726 zirconium Inorganic materials 0.000 description 9
- 230000002285 radioactive effect Effects 0.000 description 8
- 239000008227 sterile water for injection Substances 0.000 description 8
- 239000004743 Polypropylene Substances 0.000 description 7
- 229920001155 polypropylene Polymers 0.000 description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 6
- ZOKXTWBITQBERF-AKLPVKDBSA-N Molybdenum Mo-99 Chemical compound [99Mo] ZOKXTWBITQBERF-AKLPVKDBSA-N 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000003637 basic solution Substances 0.000 description 5
- UJVRJBAUJYZFIX-UHFFFAOYSA-N nitric acid;oxozirconium Chemical compound [Zr]=O.O[N+]([O-])=O.O[N+]([O-])=O UJVRJBAUJYZFIX-UHFFFAOYSA-N 0.000 description 5
- IVORCBKUUYGUOL-UHFFFAOYSA-N 1-ethynyl-2,4-dimethoxybenzene Chemical compound COC1=CC=C(C#C)C(OC)=C1 IVORCBKUUYGUOL-UHFFFAOYSA-N 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 4
- 240000002834 Paulownia tomentosa Species 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910007729 Zr W Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- OJLGWNFZMTVNCX-UHFFFAOYSA-N dioxido(dioxo)tungsten;zirconium(4+) Chemical compound [Zr+4].[O-][W]([O-])(=O)=O.[O-][W]([O-])(=O)=O OJLGWNFZMTVNCX-UHFFFAOYSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 238000009428 plumbing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052713 technetium Inorganic materials 0.000 description 2
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 2
- OERNJTNJEZOPIA-UHFFFAOYSA-N zirconium nitrate Chemical compound [Zr+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O OERNJTNJEZOPIA-UHFFFAOYSA-N 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- 229910052684 Cerium Inorganic materials 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000005255 beta decay Effects 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000001457 metallic cations Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229950009740 molybdenum mo-99 Drugs 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003439 radiotherapeutic effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000002990 reinforced plastic Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940056501 technetium 99m Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
RHENIUM GENERATOR SYSTEM AND METHOD
FOR ITS PREPARATION AND USE
Abstract A process for preparing a tungsten-188/rhenium-188 generator having a tungstate matrix containing W-188 produced by irradiating tungsten-186 in the tungstate compound. High activity, carrier-free rhenium-188 may be obtained by elution. Substrates for further purifying the rhenium-188 eluate are also described.
FOR ITS PREPARATION AND USE
Abstract A process for preparing a tungsten-188/rhenium-188 generator having a tungstate matrix containing W-188 produced by irradiating tungsten-186 in the tungstate compound. High activity, carrier-free rhenium-188 may be obtained by elution. Substrates for further purifying the rhenium-188 eluate are also described.
Description
RHENI~ GENERATORSYSTEM AND M~THOD
FORITSPREPARATION AND USE
Field of the Invention This invention relates to the production of radionuclides useful for 5 therapeutic and diagnostic medical applications, particularly to radionuclide generator systems, and more particularly to tungsten-188/rhenium-188 generators.Background of the Invention Radionuclides, meaning atomic species that exhibit radioactivity, are useful for diagnostic and therapeutic technigues such 8s tumor imaging and radiotherapyl0 of tumors~ Such techniques have increased the demand for available supplies of carrier-free radionuclides having reasonable half-lives such as Technetium-99m (Tc-99m, half-life 6.02 hours) used ~or diagnostic purposes. One method o~
obtaining such radionuclides is via extraction of a "daughter" radionuclide which is a decay product of a long-lived ("parent") radionuclide. For example, Tc-99m is l5 the daughter radionuclide of molybdenum-99 ~Mo-99, half-life 66.02 hrs).
Devices known as generators are commercially available to provide separation of a daughter radionuclide from its parent radionuclide to provide a supply of the relatively short-lived daughter isotope. The parent and daughter radionuclides may be separated using chromatographic, solvent extraction, or 20 sllblimation generators. The chromatographic generators, due to their simplicity and compact naturel are more convenient to use in hospitals and other institutions where radionuclides are used for diagnosis and therapy. For use in such generators, the parent radionuclide should have a sufficiently long half-life toprovide enough time for transit and storage prior to commencing the extraction 25 procedure.
Chromato~raphic generators, such as ehose used to produce Tc-99m from Mo-99, typically contain insolubilized parent radionuclide absorbed onto a bed or .~
~
., -2- ~ 3 ~
column of material such as aluminum oxide ("alumina") for which the daughter radionuclide has relatively little affinity. The daughter radionuclide, which forms from decay of the parent, is then periodically eluted from the column, for example using physiological saline. Typically, the daughter radionuclide productwill be of high specific activity and is referred to as "carrier free" since it is produced by beta decay of a parent radionuclide, and the product is relatively free of stable isotopes of the daughter radionuclide.
Until recently, prior chromatographic generators were only able to provide high specific activity product radionuclides at relatively low concentrations from lO low specific activity (n, y) parent radionuclides such as Mo-99 due to the necessity of using large quantities of alumina and eluting solution to obtain the daughterradionuclide. As a result, f ission-produced parent radionuclides have been preferred for producing radionuclides such as Tc-99m. Unfortunately, fission-produced radionuclides require complex facilities and safety precautions that 15 entail high costs relative to the amount of daughter radionuclide produced.
Recently, a chromatographic Mo-99/Tc-g9m generator has been developed that employs a matrix composed of zirconium molybdate containing Mo-99. Evans et al., U.S. Patent No. 4,280,053. This matrix is said to be essentially non-elutable, and to allow the Tc-99m produced in the matrix to diffuse through and 20 from the matrix during elution.
Another radionuclide which shows promise for therapeutic and diagnostic applications is rhenium-188 (Re-188), a decay product of tungsten-188 (W-188), alow specific activity isotope produced from naturally occurring tung~ten (W-186).
Although the chemical properties of rhenium are not as well known as those 25 of technetium, certain of its properties suggest it may be suited for use in radiotherapeutic applications, for example, as a label for conjugation to monoclonal antibodies for targeting to tumors. Re-188 (half-life 16.98 hours) has a longer half-life than Tc-99m (6.02 hours), possesses a strong particulate emission (beta energy of 2.12 MeV) (in contrast, Tc-99m has no particulate emission), and30 has an imageable gamma emission (15%, 155 keV) ideal for current gamma cameraimaging of tumors. W-188 radionuclide is derived from either natural tungsten (W-186) or, preferably, from a target tungsten material enriched in W-186 S
FORITSPREPARATION AND USE
Field of the Invention This invention relates to the production of radionuclides useful for 5 therapeutic and diagnostic medical applications, particularly to radionuclide generator systems, and more particularly to tungsten-188/rhenium-188 generators.Background of the Invention Radionuclides, meaning atomic species that exhibit radioactivity, are useful for diagnostic and therapeutic technigues such 8s tumor imaging and radiotherapyl0 of tumors~ Such techniques have increased the demand for available supplies of carrier-free radionuclides having reasonable half-lives such as Technetium-99m (Tc-99m, half-life 6.02 hours) used ~or diagnostic purposes. One method o~
obtaining such radionuclides is via extraction of a "daughter" radionuclide which is a decay product of a long-lived ("parent") radionuclide. For example, Tc-99m is l5 the daughter radionuclide of molybdenum-99 ~Mo-99, half-life 66.02 hrs).
Devices known as generators are commercially available to provide separation of a daughter radionuclide from its parent radionuclide to provide a supply of the relatively short-lived daughter isotope. The parent and daughter radionuclides may be separated using chromatographic, solvent extraction, or 20 sllblimation generators. The chromatographic generators, due to their simplicity and compact naturel are more convenient to use in hospitals and other institutions where radionuclides are used for diagnosis and therapy. For use in such generators, the parent radionuclide should have a sufficiently long half-life toprovide enough time for transit and storage prior to commencing the extraction 25 procedure.
Chromato~raphic generators, such as ehose used to produce Tc-99m from Mo-99, typically contain insolubilized parent radionuclide absorbed onto a bed or .~
~
., -2- ~ 3 ~
column of material such as aluminum oxide ("alumina") for which the daughter radionuclide has relatively little affinity. The daughter radionuclide, which forms from decay of the parent, is then periodically eluted from the column, for example using physiological saline. Typically, the daughter radionuclide productwill be of high specific activity and is referred to as "carrier free" since it is produced by beta decay of a parent radionuclide, and the product is relatively free of stable isotopes of the daughter radionuclide.
Until recently, prior chromatographic generators were only able to provide high specific activity product radionuclides at relatively low concentrations from lO low specific activity (n, y) parent radionuclides such as Mo-99 due to the necessity of using large quantities of alumina and eluting solution to obtain the daughterradionuclide. As a result, f ission-produced parent radionuclides have been preferred for producing radionuclides such as Tc-99m. Unfortunately, fission-produced radionuclides require complex facilities and safety precautions that 15 entail high costs relative to the amount of daughter radionuclide produced.
Recently, a chromatographic Mo-99/Tc-g9m generator has been developed that employs a matrix composed of zirconium molybdate containing Mo-99. Evans et al., U.S. Patent No. 4,280,053. This matrix is said to be essentially non-elutable, and to allow the Tc-99m produced in the matrix to diffuse through and 20 from the matrix during elution.
Another radionuclide which shows promise for therapeutic and diagnostic applications is rhenium-188 (Re-188), a decay product of tungsten-188 (W-188), alow specific activity isotope produced from naturally occurring tung~ten (W-186).
Although the chemical properties of rhenium are not as well known as those 25 of technetium, certain of its properties suggest it may be suited for use in radiotherapeutic applications, for example, as a label for conjugation to monoclonal antibodies for targeting to tumors. Re-188 (half-life 16.98 hours) has a longer half-life than Tc-99m (6.02 hours), possesses a strong particulate emission (beta energy of 2.12 MeV) (in contrast, Tc-99m has no particulate emission), and30 has an imageable gamma emission (15%, 155 keV) ideal for current gamma cameraimaging of tumors. W-188 radionuclide is derived from either natural tungsten (W-186) or, preferably, from a target tungsten material enriched in W-186 S
by double neutron capture u~ing a hlgh-flux reactor. The nuclear propertles of this i50topic sy~tem are as follows:
W-186 (n,~) W-187 jn,~) W-188 (sta~le3 (23.9 hr) (69.4d) ,~ _ ,9 _ Re-187 Re-188 (stable) (16.98 hr3 Os-188 (stable) Previous tungsten/rhenlum generators have consisted of ~mall, alumlna columns wlth relatively small amounts of tungsten targets adsorbed on the columns and, thus, low rhenlum yields ln the mlcrocurle t~Cl) range. To lncrea~e the a~ount of rhenlum obtainable from ~uch columns (i.e., ln the mlllicurie range, mCl), larger column mas~es are necessary ln order to contaln larger amount~ of target tungsten. The~e larger columns, in turn, requlre lncreased elutlng volumes.
In addltlon, prlor W-188/Re-188 generators u~ing alumlna columns have provlded poor yleld~ of Re-188 and unacceptable level6 of rele~3e, or "breakthrough" of W-188 from the column due prlmarily to the necesslty of adsorblng large (0.5 - 2.0 grams) amount~ of target tungsten (prlmarily as W-186) onto the alumlna column. A W-188/Re-188 generator s~stem lncorporatlng larger amoUnt# of target tung3ten to produce hlgh yleld~ ~mllll~uxies) of carrier-free Re-188 ln ~mall volu~es (mllllllters) ~lthout signlflcant W-188 contamination would be u~eful for therapeutlc and dlagno~tlc appllcatlons.
~ummarv of the Inventlon Accordlngly, the pre~ent lnvention provides a process for preparlng a tungsten-188/rhenlua-188 generator e~ploylng a ~ ~B
~ ,~ " ~ 3 4 62~39-1030 tungstate yenerator matrlx containing low specific activlty W-188 pxoduced by lrradlating ~-186. The matrix may be placed in an elutable container, such aæ a column, for harve~ting substantially carrier-free, high specific activity Re-188. The proce~s for preparing the generator matrix, composed of tungsten trioxide and zirconium, includes dis~olving irradiated tung~ten trioxide ln a heated basic ~olution and adding thls solution to an acidic zirconium-containing solution to form an acidic slurry in which zirconyl tungstate preclpitate form~. The acidlc ~olution optionally may contain an lnert filler such as an inorganic metal oxlde. Particularly preferred fillers include silica, quartz, alumina, magnesium oxide and dlatomaceous earth. An alternatlve process for preparing the generator of the present invention includes the additlonal step of ad~usting the pH of the pr~cipitate from about 2.8 to about 6.0, preferably about 4.3.
Also, the ~lurry may be neutralized uslng a ba~lc solution. W-188 radionucllde produced by lrradlatlon is contalned within the precipltate used to form the generator matrlx. Rhenlum-188 may be recovered by eluting the generator matrix wlth a sallne solution, and the eluate may be further purified using an alumina or zlrconium oxlde substrate.
Detailed De~crl~tlon The pre~ent lnventlon provldes a process for preparlng a W-188/Re-188 generator in the form of a substantially in~oluble matrlx containlng W-188 whlch 18 permeable to dlffuslon of Re-188 ln the form of the perrhenate lon (ReO4 ). The natrlx is preferably composed of a W-186 tungsten-containing ~aterial, ~uch as a tungstate compound, whlch is irrad~ated to form relatively 4a 62839-1030 low specific activity W-188. The resulting parent radionuclide material is then dissolved in a heated basic solution, which is then combined with an acidic zirconium solution to precipitate the zirconyl tungstate matrix. The matrix, which contains the parent radionuclide W-188, may then be placed in a container for harvesting the de~ired high specific activlty daughter radionucllde Re-188 by elution. Details of the preparation of the generator matrlx and its use are described below.
The invention also provides a Re-188 generator comprising an elutable container deflning an eluant flow path, sald container containing a first matrix comprising a substantially non-elutable tungstate compound containing W-188 and a second matrix comprislng a tungsten-188 specific substrate, sald first and second matrices being dispo6ed in said flow path to sequentially contact eluant with the first matrix and then the second matrlx.
The invention further provldes a radlonucllde generator for producing rhenium-188 comprl~lng a substantlally lnsoluble matrlx conslsting essentlally of a tungstate compound contalning tungsten-188, ~ald matrix belng permeable to fluld passage and permlttlng dlffusion of rhenium-188 therethrough.
The substantially insoluble precipltate containing the parent radionucllde, W-188, ls prepared for use in formlng a permeable matrix which allows a hlgh rate of dlffuslon of the daughter radtonucllde lon (ReO4 ) generated as a decay product of the parent. Through thls procedure, the Re-188 is produced in high yield and at a relaeively hlgh specific activity uslng si~ple - elution methods, wlthout requlring large beds or columns and thus ~ B~
4b 62839-1030 the large elution volumes of prior methods. Tungsten (W) in the form of a tung~tate compound, derived from tungsten-186 trioxide (W03) or tung~ten metal, when suitably combined wlth a soluble salt of a metallic cation, ~uch a~ zirconyl (ZrO+2), to form a precipltate, provides a matrix that is highly insoluble in solution~ 6uch as physiological ~aline that is commonly used to elute chromatographic generator~.
The tungsten starting material i8 lrradlated at high neutron flux levels using, for example, a 10 ~egawatt nuclear reactor to produce W-188, the parent radlonucllde. Slnce tungsten trloxide ls unstable in acld, to form the tungstate precipitate, the irradiated tungsten trioxide 1~ preferably inltlally dlssolved ln a basic solutlon wlth a hydroxyl concentratlon ([OH ]) of from 2 to 10 moles~llter. The base may be sodlum hydroxlde, potassium hydroxlde, ammonlum hydroxlde or a slmilar source of hydroxyl ion.
Preferably, the basic solution has been heated to a temperature in the range of 50C to 60C to dlssolve the tungsten trloxlde. A
more preferred heatlng range 18 70C to 90C. The resulting ~olutlon may then be cooled to room temperature and combined wlth 20 an acldic aqueous solution, such a~ hydrochloric acid (HCl), nitric acid (HN03) or sulfuric acid (H2S04) with a hydrogen ion concentratlon ~[H ]) of from 1 to 6 moles/liter and preferably from 4 .
. .
, ',:
'~' .
_S~ r $
to 5 moles/liter, and containing zirconyl iOl1. It was found that when the basic and acidic solutions were combined at temperatures in the range of from approximately 5C to 80C, for each solution, the precipitation of zirconyl tungstate still occurred.
In commercial production of radionuclide generators large quantities of tungsten are necessary. Accordingly, because of its high mass to volume ratio, tungsten metal is a preferred starting material. Unlike tungsten trioxide, tungsten metal is converted to tungstate by dissolving the metal in an acidic solution, e.g., hydrofluoric acid and nitric acid. For example, tungsten metal and 48% hydrofluoric acid are placed in a Teflon beaker, whereupon concentrated nitric acid is added to the mixture to produce a clear solution. The solution isthen evaporated to dryness under gentle heat to remove excess hydrofluoric acid.The resulting solid is then redissolved in base to produce the basic tungstate solution used in the present invention.
The pH of the acidic and basic solutions is selected to produce a final slurry or gel which remains acidic (pH 0 to 1) after the addition of the basic tungstensolution. It is preferable to slowly add the basic tungsten solution to the acidsolution and not the acidic solution to the basic solution, to promote formation of zirconyl tun~state. Slow addition can be achieved, for example, by drop-wise addition. This is because of the tendency of the zirconyl cation to form zirconium hydroxide, which reaction competes with the reaction of zirconyl cation and tungsten, potentially reducing the amount of zirconyl tungstate formed. In addition, because a certain amount of zirconium hydroxide will tend to form in the base of the combined solutions, a slight excess (preferably from 25% to 50%) of zirconium may be used to ensure formation of a zirconyl tungstate precipitate containing a 1:1 ratio of zirconium to total tungsten, thus compensating for theloss of some zirconyl to zirconium hydroxide. After precipitation, the slurry isadjusted to a pH of from 5 to 7, preferably about 2.8 to about 6.0, and most preferably about 4.3. Such pH controls enhance the elution efficiency of the generator of the present invention. Although the inventors do not wish to be bound by any theory, they believe that the pH control of the final precipitate improves the lattice structure of the gel matrix. A base such as sodium hydroxide (NaOH), to prevent redissolving of the zirconyl tungstate, may be used to adjustthe pH of the precipitate. Any ~irconium hydroxide which forms from the excess 35 zirconyl cation used, as described above, may precipitate when the slurry is adjusted to a basic pH. This precipitate rnay remain associated with the matrix and adsorb any solubilized tungsten released from the matrix which would otherwise contaminate the eluate.
The slurry is centrifuged and the precipitate is washed several times using deionized water or physiological saline and is filtered to remove any soluble tungsten (W-186 and W-188) not initially precipitated and, then, preferably, theprecipitate is slowly air dried to remove excess liquid at room temperature.
Alternatively, the precipitate may be oven dried, for example, at 100C. The resu;ting glassy material which remains hydrated, is broken up, for example, using a spatula or by sonication to form the generator matrix material.
The commercial expedients of small volume and high efficiency for 10 radionuclide generators require that particle size and shape be uniform to enhance the packing and elution characteristics of the generators. Unfortunately, the glassy nature of the precipitate makes it very difficult to break up and grind into uniform particles for column preparation. This is a significant practical problem. However, the inventors have discovered that uniform particles can be 15 achieved more readily by addition of an inert filler, for example an inorganic metal oxide, to the acidic zirconyl solution prior to reaction with the basic tungstate solution. The weight:volume ratio of filler to zirconyl solution is in the range of about 0.2% to about 5.0%, preferably about 1.0%. Examples of inert fillers include silica, quartz, alumina, magnesium, and diatomaceous earth.
A preferred purification protocol employing centrifugation and washing, rather than filtering, also improves the uniformity of particle size and elutionefficiency. The preferred protocol requires at least three centrifugation/washing/decanting steps sequentially with water, a polar organic solvent miscible with water, and an organic solvent miscible with the polar 25 organic solvent. Adequate washing requires sufficient volumes of wash solution relative to mother liquid at least in a ratio of about 1:5, e g., 4 ml of wash per 20 ml of mother liquid, preferably in a ratio of about 1:1. This protocol removes soluble salts as well as water from the precipitate that may cause undesirable association between particles. Also, in contrast to air or heat drying, the 30 precipitate is ground more easily into uniform particles. Accordingly, addition of an inert filler may not be necessary. Examples of polar solvents useful in the preferred purification protocol include acetone, acetonitrile, ethanol, methanol, and methylethyl ketone. Preferablv, the organic solvent is selected to have a low boiling point to accelerate drying of the precipitate. Examples of organic solvents 3~ include diethylether, petroleum ether, hexane, pentane, methylene chloride, chloroform, tetrahydrofurane, di-isopropyl ether, and benzene.
The matrix material may be transferred to an empty container for eluting -7- ~ 3 and harvesting of the daughter product Re-188. Suitable containers may include, for exarmple, a glass column such as those used in standard chromatography whichis then encased in a "shell" including appropriate lead shielding, associated plumbing and a reservoir of eluant, to form a generator assembly. Alternatively,a separate, sterile reservoir may be supplied for each series of elutions. It isdesirable, but not essential, to keep the matrix hydrated at all times.
Periodically, the daughter Re-188 is conveniently eluted from the column using eluant solutions, such as water or saline, for example sodium chloride (NaCI) orsodium sulfate (Na2SO4)~ Physiological saline, preferably with a molarity of 0.15, is a preferred eluant solution.
Performance of the rhenium generator of the present invention may be expressed as elution efficiency. Elution efficiency may be calculated by measuring the amount of radioactivity of Re-188 present in the eluant divided bythe amount of radioactivity of Re-188 originally present on the generator column, immediately prior to elution. The radioactivity of the Re-188 may be determined using standard instruments for measuring radioactivity including gamma ray spectrophotometers such as germanium detectors and sodium iodide scintillation spectrophotometers, which are capable of measuring low levels of radioactivity, or dose cslibrators that can measure high levels of radioactivity. In the present invention, since the generator consists of a small column, the entire column maybe placed in a dose calibrator to directly measure the radioactivity of Re-188 on the column before elution, and by subtracting from this value the amount of radioactivity of Re-188 on the column after elution, the amount of radioactivityof the Re-188 present in the eluant may be determined. This procedure provides aclose approximation of the Re-188 present in the eluant because, at the appropriate setting on the dose calibrator, the radioactivity measured on the column may be attributed to Re-188. Elution efficiencies are typically measured after approximately 3 to 10 Re-188 half-lives. Elution efficiencies of Re-188 ashigh as 55% - 6S% have been obtained using the generators of the present 30 invention, with concentrations of Re-188 in the eluant of up to 4 mCi/ml and higher, determined immediately after elution and typically after 3 or 4 half-lives.
The radiochemical purity of Re-188 may be assessed using ion exchange, reversed phase high-performance liquid chromatography (HPLC) or scintillator chromatography using nonradioactive perrhenate as a standard.
While zirconyl tungstate (ZrOWO4), or ZrOWO4 XH2O when hydrated, is the preferred compound îor forming the matrices used to generate Re-188 in the present invention, other suitable matrices include tungstate compounds containing ~~ -8- ~L t~ h ~J ~ -r ~
hafnium, titanium, cerium, iron, tin and barium, and mixtures of these compounds.
During the elution process, a certain amount of W-188 and W-186 in the eluant may be released from the matrix, for example, in the form of small particles of the zirconyl tungstate matrix, causing contamination of the Re-188.5 A porous glass or plastic structure, such as a fritted glass disc used in chromatography columns, may be used to retain some of these particles to prevententry of tungsten into the eluate. However, the amount of W-188 released from the column is relatively low using the process of this invention (as low as 0.01%).
This is because, in the present invention, a large fraction of the generator matrix 10 would have to dissolve before a substantial fraction of the W-188 cantained in it is released. Using the generator of the present invention, Re-188 may be eluted with less than 0.01% (of the total W-188 present on the column) breakthrough of W-188. Moreover, the level of W-188 present in the eluate may be reduced by several orders of magnitude using a substrate which is capable of adsorbing 15 tungsten including W-188, such as an alumina column or zirconium hydroxide bed, to purify the solution eluted from the zirconyl tungstate matrlx. Thus, the generator system of the present invention may include a second elutable container, such as chromatographic column enclosing a second matrix containing such a tungsten-specific matrix, for removing any released W-188, in addition to20 the container enclosing the generator matrix. Alternatively, the substrate which is capable of adsorbing tungsten may be incorporated into the generator column, for example below the zirconyl tungstate matrix, so that the eluant passes through the substrate after first flowing through the zirconyl tungstate matrix. An additional advantage of the use of the tungsten-adsorbing substrate is that the loss 25 of small particles of matrix may be minimized, which in turn decreases the amount of eluted fluid containing such contamination particles which must be disposed of.
W-188/Re-188 generator devices made according to the present invention are quite compact and may be made using small masses of generator matrix.
30 Since the W-188 can be produced at a specific activity of approximately 1 Curie (Ci)/gram or higher by neutron capture, it is apparent that small (Curie size) generator columns containing volumes as low as 5 ml may be constructed using this process.
Although the generators of the present invention offer significant 35 advantages over the prior art, the cost of the W/Re generators is significantly higher than most prior art radionuclide generators, e.g., molybdenum/technetium generators, primarily because of the more expensive W-186 starting material.
9 ~ ~i h ~
Accordingly, there is significant economic motivation to develop a method for recycling and extraction of the tungsten-186 from generators that have already been fully exhausted by elution. Although no longer clinically useful, exhaustedgenerators still could contain large amounts of radioactivity, e.g., as much as 200 mCi of W-188, even after a few months since the half-life of W-188 is about 70 days. Thus, the present invention is also directed to methcds for extracting thetungsten content from the exhausted zirconium tungstate gel. Once recovered, W-186 can be irradiated to form W-188 for use in preparing new generators. The basic recycling process comprises dissolving the zirconium tungstate gel or matrix, separating the zirconium from the tungsten, and isolating the tungsten.
Dissolution of the gel can be achieved by reacting with strong acid solutions, for example concentrated hydrochloric acid. The separation step can be achieved, forexample, by addition of a strong base to the gel solution which will dissolve the tungstate fraction of the gel while zirconium will precipitate out as zirconium l 5 oxide. Isolation can be accomplished, for example, by filtering the resulting solution, washing the precipitate, and recovering the filtrate containing tungsten. The tungsten is isolated in the filtrate and the volume is reduced. The tungsten can be recovered in one of two ways. First, the concentrated tungstate solution is heated causing evaporation of the water and forming tungsten trioxide;
then by using a hydrogen reduction step under high pressure and temperature, thetungsten trioxide is converted to tungsten metal. This method, which is easily applied to enriched or non-radioactive tungsten, could be applicable to radioactive samples. A second approach comprises using the technique of electroplating.
Using the following equation, a current of a predetermined intensity is passed through the concentrated tungstate solution, producing the deposition of tungsten metal at the cathode:
WO,L + 4H20 + 6e ~ W + 8 OH EO = -1.OSV
The cathode can be conveniently formed from W-186 enriched wire or foil, the mass of which would then be increased by the amount of tungsten metal deposited on the cathode. For example, a wire of 0.25 mm in diameter and 20 cm in length would correspond to 200 mg of tungsten metal. The wire could then be prepared for a new cycle of irradiation to W-188.
The following Exsmples are presented ~o illustrate the rdvxnta~es r,~ the ' :
present invention and to assist one of ordinary skill in making and using the same. The Examples are not intended in any way to otherwise limit the scope of the disclosure or the protection granted by Letters Patent hereon.
EXA~IPLE 1 5 Preparation of W-188 116 mg of isotopically enriched W-186 in the form of tungsten trioxide (Oak Ridge National Laboratories, Oak Ridge, TN) was neutron-irradiated at 3 X 1014 neutrons/cm2/sec for four to five months using the Missouri University Research Reactor to produce approximately 60 mCi of W-188 in the 116 mg of tungsten l 0 trioxide.
Preparation of Zirconyl-Tungstate Precipitate 116 mg of tungsten trioxide, irradiated as describPd above after decaying four months to a total activity of approximately 14 mCi, was added to 134 mg of non-irradiated WO3 to equal 250 mg of WO3, which was dissolved in 5 ml of 5 M
sodium hydroxide (NaOH) heated to 60C. The resulting basic tungsten trioxide solution was allowed to cool to room temperature, and then slowly added to an acidic solution, approximately 7.5 ml of 4 M HCl (to provide an excess of acid in the final solution) and containing 0.45 grams of zirconium nitrate (approximately 25% excess zirconium to ensure precipitation). The final slurry had a pH of 0 to 1 after addition of the basic tungsten solution. A white zirconyl tungstate precipitate formed immediately upon stirring and was neutralized using NaOH to apH in the range of approximately S to 7 to prevent redissolving of the precipitate. The precipitate was then isolated by filtration and washed with physiological saline (0.9% NaCl) and then slowly dried at 25C. The resulting glassy-white material was broken up using a spatula and transferred to an empty glass colùmn (approximate volume 5-7 ml), containing a fritted glass disc (Mallinckrodt, Inc., St. Louis, MO). In the column, the matrix was again washed using physiological saline to release and remove any small particles from the matrix, to prevent entry of tungsten into the eluate, i.e., to reduce breakthrough. Water may also be used to wash the column.
W-188 was found to comprise less than 0.003% of the generator matrix, as determined from the radioactivity (mCi) of W-188 as measured using a dose calibrator.
Rhenium Generator The above generator matrix column was fitted within a conventional housing of lead shielding, also containing an eluant reservoir and associated plumbing.
Prior to the initial elution, the column was again washed using approximately '? ~ 5~
500 ml of physiological saline, to further reduce breakthrough from the matrix.
Re-188 was then allowed to generate from approximately 7 mCi of W-188 within the column for 1 to 2 days after which the Re-188 was eluted using 5 to 10 ml ofphysiological saline. 4 mCi of Re-188 in the form of ReO4 was obtained in the initial elution using the above procedure. Subsequently, 2 to 4 mCi of Re-188 was obtained from each elution over a three-week time period, using a single elutionevery other day.
The concentration profile (mCi/ml of eluate) of Re-188 obtained from the generator may be determined by measuring the radioactivity of the Re-188 10 obtained in a given volume of eluate for several solutions. These measurements may be compared to the total amount of radioactivity of the Re-188 generated on the column to determine at what time point in elution the highest activity of Re-188 is obtained. In addition, the specific activity of Re-188 obtained from the column may be measured by determining the total radioactivity of Re-188 present 15 in the eluate from the column.
Elution Purity To determine the amount of W-188 released from the matrix, eluates obtained as described above were analyzed using a multichannel analyzer (NuclearData, Inc., Schaumburg, IL) which showed that the W-188 content of the Re-188 20 solutions was between .008-.01% of total activity on the column. The amount of breakthrough of W-188 was further reduced by passage over an alumina column or hydrous zirconium oxide adsorbent bed. No other significant radionuclide impurities were present.
Nonradioactive chemical impurities such as metals present in the eluates 25 may be examined using atomic absorption of elutions.
Radiochemical Purity of Re-188 -Perrhenate was the only material detected on an HPLC column after elution of the W-188~Re-188 generators described above.
Generator Performance Generator performance was measured in terms of elution efficiency as described above using a sodium iodide spectrophotometer and a dose calibrator.
Generator efficiencies were found to be from 55% to 65%.
The generator described herein may be made to hold from several hundred milligrams up to 1 gram of target tungsten trioxide to provide daughter Re-188 yields of several hundred millicuries.
Reusability of Generator The generator prepared as described above was eluted regularly every other -12- 1 c~
day for 2 to 3 weeks, producing an average elution yield of 59%. Other W-188/Re-188 generators made according to the proeess described herein were found to givesimilarly consistent high yields over several months' time. This demonstrates that generators as described herein have a useful lifetime for production of Re-188.
The present invention avoids the need to use a high specific activity parent radionuclide produced from fission. Since W-188 is unlikely to be available carrier-free in the foreseeable future, the present invention, which uses W-188 produced from W-186, provides a convenient means for obtaining carrier-free Re-188 in useful quantities without requiring large columns which are difficult to shield and which require large volumes of eluate to obtain acceptable amounts ofproduct. Previous smaller Re-188 generators could not hold enough adsorbed W-188 and attempts to increase the generator activity reduced the elution yield ofRe-188 and increased release of W-188 from the column.
The Re-188 produced by the generator device described herein may be l 5 conjugated to antibodies, for example, those that recognize tumor-associated antigens, for radiotherapy or diagnostic purposes. In addition, the relatively long half-life of W-188 (69.4 days), and ready transportability o~ the generator matrix in columns or other containing devices, facilitates commercial supply and storage of the generator matrices produced according to the present invention.
Sample Preparation and Irradiation Two 250 mg preparations of isotopically enriched W-186 as tungsten trioxide (WO3) 96% enriched (1.07 mmole) were introduced into separate T-21 quartz vials. The quart~ vials were sealed with a torch under vacuum to a length of about 1.5 inches. Each seal was checked visually and with a needle probe. Each of the 250 mg preparations were then concurrently subject to the following procedure.
The sample was then irradiated in a nuclear reactor. After irradiation, the irradiated vial was returned in a numbered lead pig. After a minimum 15 days decay, the activity in the quartz vial was measured, using a dose calibrator at 217, 516, and 522 settings.
About 20 mL aqua regia was prepared by mixing about 15 mL ultrapure HCI
and about 5 mL ultrapure nitric acid in a 50 mL sterile first polypropylene cup.The quartz vial was placed in a 50 mL sterile second polypropylene cup pierced with at least 10 holes from an 18G needle. The first polypropylene cup was placed into the second polypropylene cup and left in contact for 24 hours. About 20 mL
of sterlle wuter for injeotion wes placed into e third 50 mL sterile polypropylene `:
,' .
-13- ~ 3 jj '3; ~
cup, and the second polypropylene cup was rinsed into the third cup. As much sterile water as necessary was used to rinse the quartz vial so that the wash solution showed a pH greater than pH 4 by using a pH strip indicator. The quartzvial was dried on sterile gauze and then placed in a 50 mL sterile fourth 5 polypropylene cup that contained about 20 mL of 95% ethanol. The quartz vial was dried on sterile gauze.
Dissolution of the Target The quartz vial was introducted into a radioisotope glove box. Using a scoring tool and vial breaker that have been cleaned with ethanol, the quartz vial 10 was opened in the glove box. The irradiated powder and the opened vial were placed into a sterile, pyrogen free 100 mL beaker equipped with a sterile, pyrogen free stirbar. Using a 3cc sterile disposable syringe, 2.0 mL sodium hydroxide 10 M
was withdrawn and added to the beaker containing the irradiated powder and the opened vial. Using a lOcc sterile disposable syringe, 8.0 mL of sterile water was 15 withdrawn for injection and added to the beaker containing the irradiated powder and the opened vial. The beaker was placed on a hot plate stirrer and heated gently on setting 1.6 (about 85C) while stirring for at least 15 minutes until the tungsten trioxide had dissolved. The beaker was then placed on another stirrer and stirred. Using a 3cc sterile disposable syringe without a needle, 3.0 mL
20 ultrapure HCl was withdrawn and then added slowly to the beaker over a 5 minute period. A gray precipitate was formed.
Using a sterile plastic pipette, a total of 1 mL. of hydrogen peroxide was added over a period of 1 hour, starting with 0.4 mL and followed by three times 0.2 mL every 15 minutes. Using a 3cc sterile disposable syringe, about 1.4 mL of25 sodium hydroxide 10 M then was added in a drop-wise manner as required to obtain a clear solution. Using a 10cc sterile disposable syringe, 5.0 mL of sterile water for injection was withdrawn. Using beta shielded tongs, the pieces of the quartzvial from the beaker containing the radioactive solution and drain were removed.The quartz fragments were rinsed with the water contained in the lOcc syringe 30 described above. The quartz fragments were placed in a 10 mL vial containing 2.5 mL sodium hydroxide 10 M and 2.5 mL sterile water, and set aside. The beaker was placed on a hot plate stirrer and heated gently to completely evaporate the solution while stirring. The heater setting was 75C for 25 minutes. The beaker was removed from the hot plate stirrer and cooled at room temperature for 5 35 minutes. Using a lOcc sterile disposable syringe, 8.0 mL sterile water for injection was withdrawn, and added to the beaker. The beaker was placed on a stirrer and stirred ~or complete dissolution.
--14-- ~ ~3 I A
Preparation of Zirconyl Nitrate Solution 570 mg zirconyl nitrate (2.14 mmole) was placed into a 1nO mL sterile, pyrogen free beaker equipped with a sterile, pyrogen free stirbar. The beaker was placed in the radioisotope glove box. Using a 3cc sterile disposable syringe, 2.2 5 mL ultrapure HCl was withdrawn, and added to the beaker containing the zirconyl nitrate. Using a 10cc sterile disposable syringe, 4.4 mL sterile water for injection was withdrawn, and added to the beaker containing the zirconyl nitrate. The beaker was placed on the hot plate stirrer; heated gently on setting 1.0 (about 55C) while stirring until completely dissolved. The beaker was placed on another 10 room temperature stirrer and stirred.
Precipitation of Zr-W gel A sterile disposable 10cc syringe was prepared for precipitation by removing its barrel and placing at the luer lock a sterile, disposable three-way valve. Aringstand was used to hold this syringe over the assembly made of the stirrer and 15 the beaker containing the zirconyl nitrate solution. A combination pH electrode was calibrated using a single point calibration at pH 4Ø The electrode was rinsed with sterile water for injection. The radioactive solution of the target was transferred into the sterile lUcc syringe using a beta shielded sterile disposable pipette. The two-way vslve was rotated to allow drop-wise addition of 20 radioactive solution. Using a 3cc sterile disposable syringe, 3 mL of sterile water for injection was withdrawn, and 1.5 mL added to the beaker that contained the radioactive tungsten solution. The rinse was transferred to the lOcc syringe andadded to the precipitated gel. A second rinse was made under identical conditions using the second 1.5 mL volume of water. The pH electrode was immersed into 25 the beaker containing the gel solution. The pH of the gel solution was adjusted to 4.0 - 4.3 with about 2.8 mL of sodium hydroxide 10 M. Using a 3cc sterile disposable syringe, 3 mL of sterile water for injection was withdrawn. The electrode was removed and washed with two times 1.5 mL water. The precipitated gel was stirred for 1 hour at room temperature. A filter membrane 30 was placed in the filtration apparatus, and the filtration apparatus placed on a sterile pyrogen free 500 mL filter flask. Sterile, pyrogen free reinforced plastic tubing was connected between the filter flask and another sterile flask which was connected to a sterile, vacuum hand pump. Using a shielded, sterile disposable pipette, the gel solution was placed into the filtration apparatus. Using the 35 vacuum hand pump, the ~el was filtered. The beaker that contained the gel wasrinsed two times with about 20 mL sterile water for injection, and filtered. Thegel was washed two times with about 100 mL sterile water for injection by pouring -15- ~ u ~ ~3 it on the side of the filter holder to avoid breaking the precipitate. The filtrate and washes were collected and an aliquot was withdrawn for calculation of precipitation yields.
Gel drying The gel was dried under reduced pressure of 3.0 inches of water + 0.5 inches, for at least 18 hours in the glove box at room temperature.
The dried gel was placed into a lOcc sterile, pyrogen free vial by dumping the gel onto a sterile, pyrogen free funnel. It is important to do this step very carefully as the particulates are highly radioactive. A piece of parafilm was 10 wrapped around a beta shielded spatula inside the vial containing the dried gel.
The gel was ground until small particulates were obtained. 250 mg hydrous zirconium oxide was weighed into two sterile, pyrogen free generator columns, using a calibrated microbalance. The generator column A was prepared with the funnel used previously. About two thirds of the gel required was poured into the15 funnel to pack the Zr-W generator column A. The funnel was then placed on topof generator column B and the other third of the gel was poured the same way onto generator column B. The tops of the columns were sealed using a sterile rubber septa, aluminum seals and crimpers. The columns were then wiped out with adsorbing paper to remove any radioactive particles that would adsorb onto 20 the columns. The columns were then placed in a plastic bag, then in a lead container of appropriate size.
While the present invention has been described in conjunction with the preferred embodiments, one of ordinary skill after reading the foregoing specification will be able to effect various changes, substitutions of equivsleats 25 and alterations to the methods and compositions set forth herein. It is therefore intended that the protection granted by Letters Patent hereon be limited only bythe appended claims and eguivalents thereof.
W-186 (n,~) W-187 jn,~) W-188 (sta~le3 (23.9 hr) (69.4d) ,~ _ ,9 _ Re-187 Re-188 (stable) (16.98 hr3 Os-188 (stable) Previous tungsten/rhenlum generators have consisted of ~mall, alumlna columns wlth relatively small amounts of tungsten targets adsorbed on the columns and, thus, low rhenlum yields ln the mlcrocurle t~Cl) range. To lncrea~e the a~ount of rhenlum obtainable from ~uch columns (i.e., ln the mlllicurie range, mCl), larger column mas~es are necessary ln order to contaln larger amount~ of target tungsten. The~e larger columns, in turn, requlre lncreased elutlng volumes.
In addltlon, prlor W-188/Re-188 generators u~ing alumlna columns have provlded poor yleld~ of Re-188 and unacceptable level6 of rele~3e, or "breakthrough" of W-188 from the column due prlmarily to the necesslty of adsorblng large (0.5 - 2.0 grams) amount~ of target tungsten (prlmarily as W-186) onto the alumlna column. A W-188/Re-188 generator s~stem lncorporatlng larger amoUnt# of target tung3ten to produce hlgh yleld~ ~mllll~uxies) of carrier-free Re-188 ln ~mall volu~es (mllllllters) ~lthout signlflcant W-188 contamination would be u~eful for therapeutlc and dlagno~tlc appllcatlons.
~ummarv of the Inventlon Accordlngly, the pre~ent lnvention provides a process for preparlng a tungsten-188/rhenlua-188 generator e~ploylng a ~ ~B
~ ,~ " ~ 3 4 62~39-1030 tungstate yenerator matrlx containing low specific activlty W-188 pxoduced by lrradlating ~-186. The matrix may be placed in an elutable container, such aæ a column, for harve~ting substantially carrier-free, high specific activity Re-188. The proce~s for preparing the generator matrix, composed of tungsten trioxide and zirconium, includes dis~olving irradiated tung~ten trioxide ln a heated basic ~olution and adding thls solution to an acidic zirconium-containing solution to form an acidic slurry in which zirconyl tungstate preclpitate form~. The acidlc ~olution optionally may contain an lnert filler such as an inorganic metal oxlde. Particularly preferred fillers include silica, quartz, alumina, magnesium oxide and dlatomaceous earth. An alternatlve process for preparing the generator of the present invention includes the additlonal step of ad~usting the pH of the pr~cipitate from about 2.8 to about 6.0, preferably about 4.3.
Also, the ~lurry may be neutralized uslng a ba~lc solution. W-188 radionucllde produced by lrradlatlon is contalned within the precipltate used to form the generator matrlx. Rhenlum-188 may be recovered by eluting the generator matrix wlth a sallne solution, and the eluate may be further purified using an alumina or zlrconium oxlde substrate.
Detailed De~crl~tlon The pre~ent lnventlon provldes a process for preparlng a W-188/Re-188 generator in the form of a substantially in~oluble matrlx containlng W-188 whlch 18 permeable to dlffuslon of Re-188 ln the form of the perrhenate lon (ReO4 ). The natrlx is preferably composed of a W-186 tungsten-containing ~aterial, ~uch as a tungstate compound, whlch is irrad~ated to form relatively 4a 62839-1030 low specific activity W-188. The resulting parent radionuclide material is then dissolved in a heated basic solution, which is then combined with an acidic zirconium solution to precipitate the zirconyl tungstate matrix. The matrix, which contains the parent radionuclide W-188, may then be placed in a container for harvesting the de~ired high specific activlty daughter radionucllde Re-188 by elution. Details of the preparation of the generator matrlx and its use are described below.
The invention also provides a Re-188 generator comprising an elutable container deflning an eluant flow path, sald container containing a first matrix comprising a substantially non-elutable tungstate compound containing W-188 and a second matrix comprislng a tungsten-188 specific substrate, sald first and second matrices being dispo6ed in said flow path to sequentially contact eluant with the first matrix and then the second matrlx.
The invention further provldes a radlonucllde generator for producing rhenium-188 comprl~lng a substantlally lnsoluble matrlx conslsting essentlally of a tungstate compound contalning tungsten-188, ~ald matrix belng permeable to fluld passage and permlttlng dlffusion of rhenium-188 therethrough.
The substantially insoluble precipltate containing the parent radionucllde, W-188, ls prepared for use in formlng a permeable matrix which allows a hlgh rate of dlffuslon of the daughter radtonucllde lon (ReO4 ) generated as a decay product of the parent. Through thls procedure, the Re-188 is produced in high yield and at a relaeively hlgh specific activity uslng si~ple - elution methods, wlthout requlring large beds or columns and thus ~ B~
4b 62839-1030 the large elution volumes of prior methods. Tungsten (W) in the form of a tung~tate compound, derived from tungsten-186 trioxide (W03) or tung~ten metal, when suitably combined wlth a soluble salt of a metallic cation, ~uch a~ zirconyl (ZrO+2), to form a precipltate, provides a matrix that is highly insoluble in solution~ 6uch as physiological ~aline that is commonly used to elute chromatographic generator~.
The tungsten starting material i8 lrradlated at high neutron flux levels using, for example, a 10 ~egawatt nuclear reactor to produce W-188, the parent radlonucllde. Slnce tungsten trloxide ls unstable in acld, to form the tungstate precipitate, the irradiated tungsten trioxide 1~ preferably inltlally dlssolved ln a basic solutlon wlth a hydroxyl concentratlon ([OH ]) of from 2 to 10 moles~llter. The base may be sodlum hydroxlde, potassium hydroxlde, ammonlum hydroxlde or a slmilar source of hydroxyl ion.
Preferably, the basic solution has been heated to a temperature in the range of 50C to 60C to dlssolve the tungsten trloxlde. A
more preferred heatlng range 18 70C to 90C. The resulting ~olutlon may then be cooled to room temperature and combined wlth 20 an acldic aqueous solution, such a~ hydrochloric acid (HCl), nitric acid (HN03) or sulfuric acid (H2S04) with a hydrogen ion concentratlon ~[H ]) of from 1 to 6 moles/liter and preferably from 4 .
. .
, ',:
'~' .
_S~ r $
to 5 moles/liter, and containing zirconyl iOl1. It was found that when the basic and acidic solutions were combined at temperatures in the range of from approximately 5C to 80C, for each solution, the precipitation of zirconyl tungstate still occurred.
In commercial production of radionuclide generators large quantities of tungsten are necessary. Accordingly, because of its high mass to volume ratio, tungsten metal is a preferred starting material. Unlike tungsten trioxide, tungsten metal is converted to tungstate by dissolving the metal in an acidic solution, e.g., hydrofluoric acid and nitric acid. For example, tungsten metal and 48% hydrofluoric acid are placed in a Teflon beaker, whereupon concentrated nitric acid is added to the mixture to produce a clear solution. The solution isthen evaporated to dryness under gentle heat to remove excess hydrofluoric acid.The resulting solid is then redissolved in base to produce the basic tungstate solution used in the present invention.
The pH of the acidic and basic solutions is selected to produce a final slurry or gel which remains acidic (pH 0 to 1) after the addition of the basic tungstensolution. It is preferable to slowly add the basic tungsten solution to the acidsolution and not the acidic solution to the basic solution, to promote formation of zirconyl tun~state. Slow addition can be achieved, for example, by drop-wise addition. This is because of the tendency of the zirconyl cation to form zirconium hydroxide, which reaction competes with the reaction of zirconyl cation and tungsten, potentially reducing the amount of zirconyl tungstate formed. In addition, because a certain amount of zirconium hydroxide will tend to form in the base of the combined solutions, a slight excess (preferably from 25% to 50%) of zirconium may be used to ensure formation of a zirconyl tungstate precipitate containing a 1:1 ratio of zirconium to total tungsten, thus compensating for theloss of some zirconyl to zirconium hydroxide. After precipitation, the slurry isadjusted to a pH of from 5 to 7, preferably about 2.8 to about 6.0, and most preferably about 4.3. Such pH controls enhance the elution efficiency of the generator of the present invention. Although the inventors do not wish to be bound by any theory, they believe that the pH control of the final precipitate improves the lattice structure of the gel matrix. A base such as sodium hydroxide (NaOH), to prevent redissolving of the zirconyl tungstate, may be used to adjustthe pH of the precipitate. Any ~irconium hydroxide which forms from the excess 35 zirconyl cation used, as described above, may precipitate when the slurry is adjusted to a basic pH. This precipitate rnay remain associated with the matrix and adsorb any solubilized tungsten released from the matrix which would otherwise contaminate the eluate.
The slurry is centrifuged and the precipitate is washed several times using deionized water or physiological saline and is filtered to remove any soluble tungsten (W-186 and W-188) not initially precipitated and, then, preferably, theprecipitate is slowly air dried to remove excess liquid at room temperature.
Alternatively, the precipitate may be oven dried, for example, at 100C. The resu;ting glassy material which remains hydrated, is broken up, for example, using a spatula or by sonication to form the generator matrix material.
The commercial expedients of small volume and high efficiency for 10 radionuclide generators require that particle size and shape be uniform to enhance the packing and elution characteristics of the generators. Unfortunately, the glassy nature of the precipitate makes it very difficult to break up and grind into uniform particles for column preparation. This is a significant practical problem. However, the inventors have discovered that uniform particles can be 15 achieved more readily by addition of an inert filler, for example an inorganic metal oxide, to the acidic zirconyl solution prior to reaction with the basic tungstate solution. The weight:volume ratio of filler to zirconyl solution is in the range of about 0.2% to about 5.0%, preferably about 1.0%. Examples of inert fillers include silica, quartz, alumina, magnesium, and diatomaceous earth.
A preferred purification protocol employing centrifugation and washing, rather than filtering, also improves the uniformity of particle size and elutionefficiency. The preferred protocol requires at least three centrifugation/washing/decanting steps sequentially with water, a polar organic solvent miscible with water, and an organic solvent miscible with the polar 25 organic solvent. Adequate washing requires sufficient volumes of wash solution relative to mother liquid at least in a ratio of about 1:5, e g., 4 ml of wash per 20 ml of mother liquid, preferably in a ratio of about 1:1. This protocol removes soluble salts as well as water from the precipitate that may cause undesirable association between particles. Also, in contrast to air or heat drying, the 30 precipitate is ground more easily into uniform particles. Accordingly, addition of an inert filler may not be necessary. Examples of polar solvents useful in the preferred purification protocol include acetone, acetonitrile, ethanol, methanol, and methylethyl ketone. Preferablv, the organic solvent is selected to have a low boiling point to accelerate drying of the precipitate. Examples of organic solvents 3~ include diethylether, petroleum ether, hexane, pentane, methylene chloride, chloroform, tetrahydrofurane, di-isopropyl ether, and benzene.
The matrix material may be transferred to an empty container for eluting -7- ~ 3 and harvesting of the daughter product Re-188. Suitable containers may include, for exarmple, a glass column such as those used in standard chromatography whichis then encased in a "shell" including appropriate lead shielding, associated plumbing and a reservoir of eluant, to form a generator assembly. Alternatively,a separate, sterile reservoir may be supplied for each series of elutions. It isdesirable, but not essential, to keep the matrix hydrated at all times.
Periodically, the daughter Re-188 is conveniently eluted from the column using eluant solutions, such as water or saline, for example sodium chloride (NaCI) orsodium sulfate (Na2SO4)~ Physiological saline, preferably with a molarity of 0.15, is a preferred eluant solution.
Performance of the rhenium generator of the present invention may be expressed as elution efficiency. Elution efficiency may be calculated by measuring the amount of radioactivity of Re-188 present in the eluant divided bythe amount of radioactivity of Re-188 originally present on the generator column, immediately prior to elution. The radioactivity of the Re-188 may be determined using standard instruments for measuring radioactivity including gamma ray spectrophotometers such as germanium detectors and sodium iodide scintillation spectrophotometers, which are capable of measuring low levels of radioactivity, or dose cslibrators that can measure high levels of radioactivity. In the present invention, since the generator consists of a small column, the entire column maybe placed in a dose calibrator to directly measure the radioactivity of Re-188 on the column before elution, and by subtracting from this value the amount of radioactivity of Re-188 on the column after elution, the amount of radioactivityof the Re-188 present in the eluant may be determined. This procedure provides aclose approximation of the Re-188 present in the eluant because, at the appropriate setting on the dose calibrator, the radioactivity measured on the column may be attributed to Re-188. Elution efficiencies are typically measured after approximately 3 to 10 Re-188 half-lives. Elution efficiencies of Re-188 ashigh as 55% - 6S% have been obtained using the generators of the present 30 invention, with concentrations of Re-188 in the eluant of up to 4 mCi/ml and higher, determined immediately after elution and typically after 3 or 4 half-lives.
The radiochemical purity of Re-188 may be assessed using ion exchange, reversed phase high-performance liquid chromatography (HPLC) or scintillator chromatography using nonradioactive perrhenate as a standard.
While zirconyl tungstate (ZrOWO4), or ZrOWO4 XH2O when hydrated, is the preferred compound îor forming the matrices used to generate Re-188 in the present invention, other suitable matrices include tungstate compounds containing ~~ -8- ~L t~ h ~J ~ -r ~
hafnium, titanium, cerium, iron, tin and barium, and mixtures of these compounds.
During the elution process, a certain amount of W-188 and W-186 in the eluant may be released from the matrix, for example, in the form of small particles of the zirconyl tungstate matrix, causing contamination of the Re-188.5 A porous glass or plastic structure, such as a fritted glass disc used in chromatography columns, may be used to retain some of these particles to prevententry of tungsten into the eluate. However, the amount of W-188 released from the column is relatively low using the process of this invention (as low as 0.01%).
This is because, in the present invention, a large fraction of the generator matrix 10 would have to dissolve before a substantial fraction of the W-188 cantained in it is released. Using the generator of the present invention, Re-188 may be eluted with less than 0.01% (of the total W-188 present on the column) breakthrough of W-188. Moreover, the level of W-188 present in the eluate may be reduced by several orders of magnitude using a substrate which is capable of adsorbing 15 tungsten including W-188, such as an alumina column or zirconium hydroxide bed, to purify the solution eluted from the zirconyl tungstate matrlx. Thus, the generator system of the present invention may include a second elutable container, such as chromatographic column enclosing a second matrix containing such a tungsten-specific matrix, for removing any released W-188, in addition to20 the container enclosing the generator matrix. Alternatively, the substrate which is capable of adsorbing tungsten may be incorporated into the generator column, for example below the zirconyl tungstate matrix, so that the eluant passes through the substrate after first flowing through the zirconyl tungstate matrix. An additional advantage of the use of the tungsten-adsorbing substrate is that the loss 25 of small particles of matrix may be minimized, which in turn decreases the amount of eluted fluid containing such contamination particles which must be disposed of.
W-188/Re-188 generator devices made according to the present invention are quite compact and may be made using small masses of generator matrix.
30 Since the W-188 can be produced at a specific activity of approximately 1 Curie (Ci)/gram or higher by neutron capture, it is apparent that small (Curie size) generator columns containing volumes as low as 5 ml may be constructed using this process.
Although the generators of the present invention offer significant 35 advantages over the prior art, the cost of the W/Re generators is significantly higher than most prior art radionuclide generators, e.g., molybdenum/technetium generators, primarily because of the more expensive W-186 starting material.
9 ~ ~i h ~
Accordingly, there is significant economic motivation to develop a method for recycling and extraction of the tungsten-186 from generators that have already been fully exhausted by elution. Although no longer clinically useful, exhaustedgenerators still could contain large amounts of radioactivity, e.g., as much as 200 mCi of W-188, even after a few months since the half-life of W-188 is about 70 days. Thus, the present invention is also directed to methcds for extracting thetungsten content from the exhausted zirconium tungstate gel. Once recovered, W-186 can be irradiated to form W-188 for use in preparing new generators. The basic recycling process comprises dissolving the zirconium tungstate gel or matrix, separating the zirconium from the tungsten, and isolating the tungsten.
Dissolution of the gel can be achieved by reacting with strong acid solutions, for example concentrated hydrochloric acid. The separation step can be achieved, forexample, by addition of a strong base to the gel solution which will dissolve the tungstate fraction of the gel while zirconium will precipitate out as zirconium l 5 oxide. Isolation can be accomplished, for example, by filtering the resulting solution, washing the precipitate, and recovering the filtrate containing tungsten. The tungsten is isolated in the filtrate and the volume is reduced. The tungsten can be recovered in one of two ways. First, the concentrated tungstate solution is heated causing evaporation of the water and forming tungsten trioxide;
then by using a hydrogen reduction step under high pressure and temperature, thetungsten trioxide is converted to tungsten metal. This method, which is easily applied to enriched or non-radioactive tungsten, could be applicable to radioactive samples. A second approach comprises using the technique of electroplating.
Using the following equation, a current of a predetermined intensity is passed through the concentrated tungstate solution, producing the deposition of tungsten metal at the cathode:
WO,L + 4H20 + 6e ~ W + 8 OH EO = -1.OSV
The cathode can be conveniently formed from W-186 enriched wire or foil, the mass of which would then be increased by the amount of tungsten metal deposited on the cathode. For example, a wire of 0.25 mm in diameter and 20 cm in length would correspond to 200 mg of tungsten metal. The wire could then be prepared for a new cycle of irradiation to W-188.
The following Exsmples are presented ~o illustrate the rdvxnta~es r,~ the ' :
present invention and to assist one of ordinary skill in making and using the same. The Examples are not intended in any way to otherwise limit the scope of the disclosure or the protection granted by Letters Patent hereon.
EXA~IPLE 1 5 Preparation of W-188 116 mg of isotopically enriched W-186 in the form of tungsten trioxide (Oak Ridge National Laboratories, Oak Ridge, TN) was neutron-irradiated at 3 X 1014 neutrons/cm2/sec for four to five months using the Missouri University Research Reactor to produce approximately 60 mCi of W-188 in the 116 mg of tungsten l 0 trioxide.
Preparation of Zirconyl-Tungstate Precipitate 116 mg of tungsten trioxide, irradiated as describPd above after decaying four months to a total activity of approximately 14 mCi, was added to 134 mg of non-irradiated WO3 to equal 250 mg of WO3, which was dissolved in 5 ml of 5 M
sodium hydroxide (NaOH) heated to 60C. The resulting basic tungsten trioxide solution was allowed to cool to room temperature, and then slowly added to an acidic solution, approximately 7.5 ml of 4 M HCl (to provide an excess of acid in the final solution) and containing 0.45 grams of zirconium nitrate (approximately 25% excess zirconium to ensure precipitation). The final slurry had a pH of 0 to 1 after addition of the basic tungsten solution. A white zirconyl tungstate precipitate formed immediately upon stirring and was neutralized using NaOH to apH in the range of approximately S to 7 to prevent redissolving of the precipitate. The precipitate was then isolated by filtration and washed with physiological saline (0.9% NaCl) and then slowly dried at 25C. The resulting glassy-white material was broken up using a spatula and transferred to an empty glass colùmn (approximate volume 5-7 ml), containing a fritted glass disc (Mallinckrodt, Inc., St. Louis, MO). In the column, the matrix was again washed using physiological saline to release and remove any small particles from the matrix, to prevent entry of tungsten into the eluate, i.e., to reduce breakthrough. Water may also be used to wash the column.
W-188 was found to comprise less than 0.003% of the generator matrix, as determined from the radioactivity (mCi) of W-188 as measured using a dose calibrator.
Rhenium Generator The above generator matrix column was fitted within a conventional housing of lead shielding, also containing an eluant reservoir and associated plumbing.
Prior to the initial elution, the column was again washed using approximately '? ~ 5~
500 ml of physiological saline, to further reduce breakthrough from the matrix.
Re-188 was then allowed to generate from approximately 7 mCi of W-188 within the column for 1 to 2 days after which the Re-188 was eluted using 5 to 10 ml ofphysiological saline. 4 mCi of Re-188 in the form of ReO4 was obtained in the initial elution using the above procedure. Subsequently, 2 to 4 mCi of Re-188 was obtained from each elution over a three-week time period, using a single elutionevery other day.
The concentration profile (mCi/ml of eluate) of Re-188 obtained from the generator may be determined by measuring the radioactivity of the Re-188 10 obtained in a given volume of eluate for several solutions. These measurements may be compared to the total amount of radioactivity of the Re-188 generated on the column to determine at what time point in elution the highest activity of Re-188 is obtained. In addition, the specific activity of Re-188 obtained from the column may be measured by determining the total radioactivity of Re-188 present 15 in the eluate from the column.
Elution Purity To determine the amount of W-188 released from the matrix, eluates obtained as described above were analyzed using a multichannel analyzer (NuclearData, Inc., Schaumburg, IL) which showed that the W-188 content of the Re-188 20 solutions was between .008-.01% of total activity on the column. The amount of breakthrough of W-188 was further reduced by passage over an alumina column or hydrous zirconium oxide adsorbent bed. No other significant radionuclide impurities were present.
Nonradioactive chemical impurities such as metals present in the eluates 25 may be examined using atomic absorption of elutions.
Radiochemical Purity of Re-188 -Perrhenate was the only material detected on an HPLC column after elution of the W-188~Re-188 generators described above.
Generator Performance Generator performance was measured in terms of elution efficiency as described above using a sodium iodide spectrophotometer and a dose calibrator.
Generator efficiencies were found to be from 55% to 65%.
The generator described herein may be made to hold from several hundred milligrams up to 1 gram of target tungsten trioxide to provide daughter Re-188 yields of several hundred millicuries.
Reusability of Generator The generator prepared as described above was eluted regularly every other -12- 1 c~
day for 2 to 3 weeks, producing an average elution yield of 59%. Other W-188/Re-188 generators made according to the proeess described herein were found to givesimilarly consistent high yields over several months' time. This demonstrates that generators as described herein have a useful lifetime for production of Re-188.
The present invention avoids the need to use a high specific activity parent radionuclide produced from fission. Since W-188 is unlikely to be available carrier-free in the foreseeable future, the present invention, which uses W-188 produced from W-186, provides a convenient means for obtaining carrier-free Re-188 in useful quantities without requiring large columns which are difficult to shield and which require large volumes of eluate to obtain acceptable amounts ofproduct. Previous smaller Re-188 generators could not hold enough adsorbed W-188 and attempts to increase the generator activity reduced the elution yield ofRe-188 and increased release of W-188 from the column.
The Re-188 produced by the generator device described herein may be l 5 conjugated to antibodies, for example, those that recognize tumor-associated antigens, for radiotherapy or diagnostic purposes. In addition, the relatively long half-life of W-188 (69.4 days), and ready transportability o~ the generator matrix in columns or other containing devices, facilitates commercial supply and storage of the generator matrices produced according to the present invention.
Sample Preparation and Irradiation Two 250 mg preparations of isotopically enriched W-186 as tungsten trioxide (WO3) 96% enriched (1.07 mmole) were introduced into separate T-21 quartz vials. The quart~ vials were sealed with a torch under vacuum to a length of about 1.5 inches. Each seal was checked visually and with a needle probe. Each of the 250 mg preparations were then concurrently subject to the following procedure.
The sample was then irradiated in a nuclear reactor. After irradiation, the irradiated vial was returned in a numbered lead pig. After a minimum 15 days decay, the activity in the quartz vial was measured, using a dose calibrator at 217, 516, and 522 settings.
About 20 mL aqua regia was prepared by mixing about 15 mL ultrapure HCI
and about 5 mL ultrapure nitric acid in a 50 mL sterile first polypropylene cup.The quartz vial was placed in a 50 mL sterile second polypropylene cup pierced with at least 10 holes from an 18G needle. The first polypropylene cup was placed into the second polypropylene cup and left in contact for 24 hours. About 20 mL
of sterlle wuter for injeotion wes placed into e third 50 mL sterile polypropylene `:
,' .
-13- ~ 3 jj '3; ~
cup, and the second polypropylene cup was rinsed into the third cup. As much sterile water as necessary was used to rinse the quartz vial so that the wash solution showed a pH greater than pH 4 by using a pH strip indicator. The quartzvial was dried on sterile gauze and then placed in a 50 mL sterile fourth 5 polypropylene cup that contained about 20 mL of 95% ethanol. The quartz vial was dried on sterile gauze.
Dissolution of the Target The quartz vial was introducted into a radioisotope glove box. Using a scoring tool and vial breaker that have been cleaned with ethanol, the quartz vial 10 was opened in the glove box. The irradiated powder and the opened vial were placed into a sterile, pyrogen free 100 mL beaker equipped with a sterile, pyrogen free stirbar. Using a 3cc sterile disposable syringe, 2.0 mL sodium hydroxide 10 M
was withdrawn and added to the beaker containing the irradiated powder and the opened vial. Using a lOcc sterile disposable syringe, 8.0 mL of sterile water was 15 withdrawn for injection and added to the beaker containing the irradiated powder and the opened vial. The beaker was placed on a hot plate stirrer and heated gently on setting 1.6 (about 85C) while stirring for at least 15 minutes until the tungsten trioxide had dissolved. The beaker was then placed on another stirrer and stirred. Using a 3cc sterile disposable syringe without a needle, 3.0 mL
20 ultrapure HCl was withdrawn and then added slowly to the beaker over a 5 minute period. A gray precipitate was formed.
Using a sterile plastic pipette, a total of 1 mL. of hydrogen peroxide was added over a period of 1 hour, starting with 0.4 mL and followed by three times 0.2 mL every 15 minutes. Using a 3cc sterile disposable syringe, about 1.4 mL of25 sodium hydroxide 10 M then was added in a drop-wise manner as required to obtain a clear solution. Using a 10cc sterile disposable syringe, 5.0 mL of sterile water for injection was withdrawn. Using beta shielded tongs, the pieces of the quartzvial from the beaker containing the radioactive solution and drain were removed.The quartz fragments were rinsed with the water contained in the lOcc syringe 30 described above. The quartz fragments were placed in a 10 mL vial containing 2.5 mL sodium hydroxide 10 M and 2.5 mL sterile water, and set aside. The beaker was placed on a hot plate stirrer and heated gently to completely evaporate the solution while stirring. The heater setting was 75C for 25 minutes. The beaker was removed from the hot plate stirrer and cooled at room temperature for 5 35 minutes. Using a lOcc sterile disposable syringe, 8.0 mL sterile water for injection was withdrawn, and added to the beaker. The beaker was placed on a stirrer and stirred ~or complete dissolution.
--14-- ~ ~3 I A
Preparation of Zirconyl Nitrate Solution 570 mg zirconyl nitrate (2.14 mmole) was placed into a 1nO mL sterile, pyrogen free beaker equipped with a sterile, pyrogen free stirbar. The beaker was placed in the radioisotope glove box. Using a 3cc sterile disposable syringe, 2.2 5 mL ultrapure HCl was withdrawn, and added to the beaker containing the zirconyl nitrate. Using a 10cc sterile disposable syringe, 4.4 mL sterile water for injection was withdrawn, and added to the beaker containing the zirconyl nitrate. The beaker was placed on the hot plate stirrer; heated gently on setting 1.0 (about 55C) while stirring until completely dissolved. The beaker was placed on another 10 room temperature stirrer and stirred.
Precipitation of Zr-W gel A sterile disposable 10cc syringe was prepared for precipitation by removing its barrel and placing at the luer lock a sterile, disposable three-way valve. Aringstand was used to hold this syringe over the assembly made of the stirrer and 15 the beaker containing the zirconyl nitrate solution. A combination pH electrode was calibrated using a single point calibration at pH 4Ø The electrode was rinsed with sterile water for injection. The radioactive solution of the target was transferred into the sterile lUcc syringe using a beta shielded sterile disposable pipette. The two-way vslve was rotated to allow drop-wise addition of 20 radioactive solution. Using a 3cc sterile disposable syringe, 3 mL of sterile water for injection was withdrawn, and 1.5 mL added to the beaker that contained the radioactive tungsten solution. The rinse was transferred to the lOcc syringe andadded to the precipitated gel. A second rinse was made under identical conditions using the second 1.5 mL volume of water. The pH electrode was immersed into 25 the beaker containing the gel solution. The pH of the gel solution was adjusted to 4.0 - 4.3 with about 2.8 mL of sodium hydroxide 10 M. Using a 3cc sterile disposable syringe, 3 mL of sterile water for injection was withdrawn. The electrode was removed and washed with two times 1.5 mL water. The precipitated gel was stirred for 1 hour at room temperature. A filter membrane 30 was placed in the filtration apparatus, and the filtration apparatus placed on a sterile pyrogen free 500 mL filter flask. Sterile, pyrogen free reinforced plastic tubing was connected between the filter flask and another sterile flask which was connected to a sterile, vacuum hand pump. Using a shielded, sterile disposable pipette, the gel solution was placed into the filtration apparatus. Using the 35 vacuum hand pump, the ~el was filtered. The beaker that contained the gel wasrinsed two times with about 20 mL sterile water for injection, and filtered. Thegel was washed two times with about 100 mL sterile water for injection by pouring -15- ~ u ~ ~3 it on the side of the filter holder to avoid breaking the precipitate. The filtrate and washes were collected and an aliquot was withdrawn for calculation of precipitation yields.
Gel drying The gel was dried under reduced pressure of 3.0 inches of water + 0.5 inches, for at least 18 hours in the glove box at room temperature.
The dried gel was placed into a lOcc sterile, pyrogen free vial by dumping the gel onto a sterile, pyrogen free funnel. It is important to do this step very carefully as the particulates are highly radioactive. A piece of parafilm was 10 wrapped around a beta shielded spatula inside the vial containing the dried gel.
The gel was ground until small particulates were obtained. 250 mg hydrous zirconium oxide was weighed into two sterile, pyrogen free generator columns, using a calibrated microbalance. The generator column A was prepared with the funnel used previously. About two thirds of the gel required was poured into the15 funnel to pack the Zr-W generator column A. The funnel was then placed on topof generator column B and the other third of the gel was poured the same way onto generator column B. The tops of the columns were sealed using a sterile rubber septa, aluminum seals and crimpers. The columns were then wiped out with adsorbing paper to remove any radioactive particles that would adsorb onto 20 the columns. The columns were then placed in a plastic bag, then in a lead container of appropriate size.
While the present invention has been described in conjunction with the preferred embodiments, one of ordinary skill after reading the foregoing specification will be able to effect various changes, substitutions of equivsleats 25 and alterations to the methods and compositions set forth herein. It is therefore intended that the protection granted by Letters Patent hereon be limited only bythe appended claims and eguivalents thereof.
Claims (19)
1. A process for preparing a radionuclide generator useful for producing Re-188, comprising the steps of:
(a) reacting a basic tungstate solution comprising W-188 with an acidic solution comprising zirconyl ion to form a zirconyl tungstate precipitate containing W-188; and, (b) disposing said zirconyl tungstate precipitate in an elutable container.
(a) reacting a basic tungstate solution comprising W-188 with an acidic solution comprising zirconyl ion to form a zirconyl tungstate precipitate containing W-188; and, (b) disposing said zirconyl tungstate precipitate in an elutable container.
2. A process for preparing a radionuclide generator useful for producing Re-188, comprising the steps of:
(a) reacting a basic tungstate solution comprising W-188 with an acidic solution comprising zirconyl ion to form a zirconyl tungstate precipitate containing W-188;
(b) adjusting the pH of said precipitate from about 2.8 to about 6; and, (c) disposing said precipitate in an elutable container.
(a) reacting a basic tungstate solution comprising W-188 with an acidic solution comprising zirconyl ion to form a zirconyl tungstate precipitate containing W-188;
(b) adjusting the pH of said precipitate from about 2.8 to about 6; and, (c) disposing said precipitate in an elutable container.
3. A process according to Claim 2, wherein said pH of the precipitate is adjusted to about 4.3.
4. A process according to Claim 2, wherein said basic tungstate solution is added to said acidic solution in a drop-wise manner.
5. A process according to Claim 2, wherein the pH of said precipitate is adjusted by addition of base.
6. A process according to Claim 2, which further comprises the additional step between steps (b) and (c) of:
sequential washing, centrifugation, and decanting with water, then a polar organic solvent miscible with water, and then an organic solvent miscible with said polar organic solvent.
sequential washing, centrifugation, and decanting with water, then a polar organic solvent miscible with water, and then an organic solvent miscible with said polar organic solvent.
7. A process according to Claim 6, wherein said polar solvent is selected from the group consisting of acetone, acetonitrile, ethanol, methanol, and methylethyl ketone.
8. A process according to Claim 6, wherein said organic solvent has a low boiling point to accelerate drying of said precipitate.
9. A process according to Claim 6, wherein said organic solvent is selected from the group consisting of diethyl ether, petroleum ether, hexane, pentane, methylene chloride, chloroform, tetrahydrofuran, di-isopropyl ether, and benzene.
10. A process according to Claim 1 or 2, wherein said acidic solution further comprises an inert filler.
11. A process according to Claim 10, wherein said filler is an inorganic metal oxide.
12. A process according to Claim 10, wherein said filler 1 selected from the group consisting of silica, quartz, alumina, magnesium oxide, and diatomaceous earth.
13. A process for preparing rhenium-188 comprising the step of eluting rhenium-188 from a matrix consisting essentially of a tungstate precipitate comprising tungsten-188.
14. The process of Claim 13, wherein said tungstate precipitate comprises zirconyl tungstate.
15. The process of Claim 13, wherein said matrix is prepared by reacting a basic tungstate solution containing W-188 with an acidic solution containing a zirconyl ion to form a zirconyl precipitate containing W-188.
16. A Re-188 generator comprising an elutable container defining an eluant flow path, said container containing a first matrix comprising a substantially non-elutable tungstate compound containing W-188 and a second matrix comprising a tungsten-188 specific substrate, said first and second matrices being disposed in said flow path to sequentially contact eluant with the first matrix and then the second matrix.
17. A radionuclide generator for producing rhenium-188 comprising a substantially insoluble matrix consisting essentially of a tungstate compound containing tungsten-188, said matrix being permeable to fluid passage and permitting diffusion of rhenium-188 therethrough.
18. The radionuclide generator of Claim 17, wherein said matrix consists essentially of zirconyl tungstate containing tungsten-188.
19. The radionuclide generator of Claim 17, wherein said matrix is prepared by reacting a basic tungstate solution containing W-188 with an acidic solution containing a zirconyl ion to form a zirconyl precipitate containing W-188.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92964486A | 1986-11-10 | 1986-11-10 | |
US929,644 | 1986-11-10 | ||
US13662787A | 1987-12-22 | 1987-12-22 | |
US136,627 | 1987-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1323748C true CA1323748C (en) | 1993-11-02 |
Family
ID=26834481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 551444 Expired - Fee Related CA1323748C (en) | 1986-11-10 | 1987-11-10 | Rhenium generator system and method for its preparation and use |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1323748C (en) |
-
1987
- 1987-11-10 CA CA 551444 patent/CA1323748C/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4859431A (en) | Rhenium generator system and its preparation and use | |
EP0541543B1 (en) | Soluble irradiation targets and methods for the production of radiorhenium | |
US5145636A (en) | Soluble irradiation targets and methods for the production of radiorhenium | |
JPS628760B2 (en) | ||
AU2004492A (en) | Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system | |
US5382388A (en) | Process for the preparation of rhenium-188 and technetium-99m generators | |
EP0494176B1 (en) | Improved radionuclide generator system and method for its preparation and use | |
Chakravarty et al. | Nanocrystalline zirconia: A novel sorbent for the preparation of 188W/188Re generator | |
US4206358A (en) | Technetium-99 generators | |
Chattopadhyay et al. | A novel 99mTc delivery system using (n, γ) 99Mo adsorbed on a large alumina column in tandem with Dowex-1 and AgCl columns | |
AU591372B2 (en) | Rhenium generator system and method for its preparation and use | |
Mansur et al. | Concentration of 99mTc-pertechnetate and 188Re-perrhenate | |
CA1323748C (en) | Rhenium generator system and method for its preparation and use | |
EP4244874B1 (en) | A method for the generation of scandium-44 | |
Chakravarty et al. | An electro-amalgamation approach to produce 175Yb suitable for radiopharmaceutical applications | |
Taskaev et al. | Extraction generator for [99mTc] sodium pertechnetate production | |
JP2966521B2 (en) | Soluble irradiation target and manufacturing method of radioactive rhenium | |
Wang et al. | Production of medical isotope 68Ge based on a novel chromatography separation technique and assembling of 68Ge/68Ga generator | |
JP4740545B2 (en) | Method for producing a desired daughter radionuclide solution free of impurities | |
RU2803641C1 (en) | Method of producing radioisotope i-161 | |
RU2091878C1 (en) | Rhenium generator production process | |
Cimpeanu et al. | High specific activity 186 Re and 188 Re perrhenates to be used for biomolecule labeling | |
IL34751A (en) | Production of fission product technetium 99-m generator | |
Cheng et al. | Investigation on preparation and properties of gel type 188W/188Re generator | |
Bokhari et al. | Lead cation exchange and alumina columns for concentration of 99m Tc-pertechnetate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |